Rolf Kaiser

Summary

Affiliation: University of Cologne
Country: Germany

Publications

  1. ncbi Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis
    Martin Daumer
    Institute of Immunology and Genetics, Pfaffplatz 10, 67655 Kaiserslautern, Germany
    BMC Med Inform Decis Mak 11:30. 2011
  2. ncbi The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
    Frank Wiesmann
    PZB Aachen, HIV and Hepatitis Research Group, Blondelstr, 52062 Aachen, Germany
    AIDS Res Ther 8:7. 2011

Detail Information

Publications2

  1. ncbi Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis
    Martin Daumer
    Institute of Immunology and Genetics, Pfaffplatz 10, 67655 Kaiserslautern, Germany
    BMC Med Inform Decis Mak 11:30. 2011
    ..Massively parallel sequencing (MPS) detects single clones thereby being much more sensitive. Using this technology we wanted to improve genotypic prediction of coreceptor usage...
  2. ncbi The L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?
    Frank Wiesmann
    PZB Aachen, HIV and Hepatitis Research Group, Blondelstr, 52062 Aachen, Germany
    AIDS Res Ther 8:7. 2011
    ..Beside an enhancement of resistance, L76V is also discussed to confer hypersusceptibility to the drugs Atazanavir and Saquinavir which might enable new treatment strategies by trying to take advantage of particular mutations...